Electrochemical biosensors for monitoring of selected pregnancy hormones during the first trimester: A systematic review.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Jun 2023
Historique:
received: 11 12 2022
revised: 20 02 2023
accepted: 23 02 2023
medline: 5 4 2023
pubmed: 5 3 2023
entrez: 4 3 2023
Statut: ppublish

Résumé

The hormones human chorionic gonadotropin, progesterone, estrogen and four of its metabolites (estradiol, estrone, estriol, estetrol), as well as relaxin play an essential role in the development of the fetus during the first trimester. Imbalances in these hormones during the first trimester have been directly linked to miscarriages. However, frequent monitoring of the hormones is limited by the current conventional centralized analytical tools that do not allow a rapid response time. Electrochemical sensing is considered an ideal tool to detect hormones owing to its advantages such as quick response, user-friendliness, low economic costs, and possibility of use in point-of-care settings. Electrochemical detection of pregnancy hormones is an emerging field that has been demonstrated primarily at research level. Thus, it is timely with a comprehensive overview of the characteristics of the reported detection techniques. This is the first extensive review focusing on the advances related to electrochemical detection of hormones linked to the first trimester of pregnancy. Additionally, this review offers insights into the main challenges that must be addressed imminently to ensure progress from research to clinical applications.

Identifiants

pubmed: 36870154
pii: S0039-9140(23)00147-9
doi: 10.1016/j.talanta.2023.124396
pii:
doi:

Substances chimiques

Hormones 0
Estradiol 4TI98Z838E
Estrone 2DI9HA706A
Progesterone 4G7DS2Q64Y
Estrogens 0
Estriol FB33469R8E
Chorionic Gonadotropin 0

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124396

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pernille Hagen Høj (PH)

Department of Science and Environment, Roskilde University, Roskilde, Denmark.

Jon Møller-Sørensen (J)

Department of Science and Environment, Roskilde University, Roskilde, Denmark.

Alberte Lund Wissing (AL)

Department of Science and Environment, Roskilde University, Roskilde, Denmark.

Fatima AlZahra'a Alatraktchi (FA)

Department of Science and Environment, Roskilde University, Roskilde, Denmark. Electronic address: alzahraa@ruc.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH